← Browse by Condition
Medical Condition
inflammatory bowel diseases
Total Trials
13
Recruiting Now
13
Trial Phases
Phase 2
ClinicalMetric tracks all active clinical trials for inflammatory bowel diseases sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — inflammatory bowel diseases Clinical Trials
How many clinical trials are currently recruiting for inflammatory bowel diseases?
ClinicalMetric currently tracks 13 actively recruiting clinical trials for inflammatory bowel diseases, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 13. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for inflammatory bowel diseases?
inflammatory bowel diseases research spans Phase 2 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a inflammatory bowel diseases clinical trial?
Eligibility criteria for inflammatory bowel diseases trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 2
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07670975
Recruiting
Enrollment
50 pts
Location
Italy
Sponsor
Azienda Ospedaliera SS. Antoni...
NCT06309017
Recruiting
Enrollment
150 pts
Location
United States
Sponsor
NYU Langone Health
NCT04401605
Recruiting
Enrollment
21 pts
Location
United States
Sponsor
Stanford University
NCT06287671
Recruiting
Enrollment
1,000 pts
Location
Denmark
Sponsor
Claus Anders Bertelsen, PhD, M...
NCT04504136
Recruiting
Enrollment
60 pts
Location
United States
Sponsor
Terrence A Barrett
NCT06537258
Recruiting
Enrollment
128 pts
Location
United States
Sponsor
Emory University
NCT06842316
Recruiting
Enrollment
100 pts
Location
France
Sponsor
Centre Hospitalier Régional d'...
NCT06256393
Recruiting
Enrollment
360 pts
Location
France
Sponsor
Nantes University Hospital
NCT06188793
Recruiting
Enrollment
40 pts
Location
United States
Sponsor
University of Michigan
NCT03855657
Recruiting
Enrollment
6,000 pts
Location
Hong Kong
Sponsor
Chinese University of Hong Kon...
NCT06553053
Recruiting
Enrollment
106 pts
Location
China
Sponsor
Shanghai Institute of Acupunct...
NCT07349472 Phase 2
Recruiting
Enrollment
60 pts
Location
Egypt
Sponsor
Ihab Elsayed Hassan
NCT06226883 Phase 2
Recruiting
Enrollment
385 pts
Location
United States, Austr...
Sponsor
Morphic Therapeutic, Inc. (A W...
Related Conditions
crohn disease colitis (1) colitis ulcerative (1) diet modification (1) ulcerative colitis (1) colorectal cancer (1) diverticulitis colonic (1) stoma colostomy (1) inflammatory disorder of immune system (1) spondylitis ankylosing (1) arthritis rheumatoid (1) arthritis psoriatic (1) sjogren s syndrome (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology